✓ Vérifié
Score de confiance 98/100
Dr. Hariharan Kuhan
· London
👤 6 ans d'expérience
6,915+
Patients seen
6
Years in practice
9
Publications
1
Languages spoken
À propos
Dr Hariharan Kuhan is the Co-Founder and Medical Director of Lucio Health, where he leads the development of personalised, data-driven approaches to cancer and metabolic health. His clinical background spans mainstream oncology, early-phase trials, and academic research, with a strong focus on integrating metabolic medicine into modern cancer care.
Dr Kuhan studied medicine at Imperial College London, graduating with a BSc in Surgery and Anaesthesia. He completed his foundation and core medical training at major central London teaching hospitals before specialising in medical oncology at recognised UK centres of excellence.
During his research fellowship at Barts Cancer Institute, he explored metabolic pathways in cancer stem cells and circulating tumour cells, contributing to translational research that progressed into phase I human trials. He later served as a clinical fellow within a Harley Street early-phase trials unit, where he acted as lead sub-investigator on multiple solid tumour studies.
Dr Kuhan continues to be actively involved in clinical research and drug development. His expertise encompasses oncology, metabolic targeting, repurposed therapeutics, and genomic profiling, giving him a distinctive ability to bridge cutting-edge science with practical, patient-centred care. He is particularly passionate about making innovative, evidence-based treatments more accessible and supporting patients through truly personalised medicine.
Dr Kuhan studied medicine at Imperial College London, graduating with a BSc in Surgery and Anaesthesia. He completed his foundation and core medical training at major central London teaching hospitals before specialising in medical oncology at recognised UK centres of excellence.
During his research fellowship at Barts Cancer Institute, he explored metabolic pathways in cancer stem cells and circulating tumour cells, contributing to translational research that progressed into phase I human trials. He later served as a clinical fellow within a Harley Street early-phase trials unit, where he acted as lead sub-investigator on multiple solid tumour studies.
Dr Kuhan continues to be actively involved in clinical research and drug development. His expertise encompasses oncology, metabolic targeting, repurposed therapeutics, and genomic profiling, giving him a distinctive ability to bridge cutting-edge science with practical, patient-centred care. He is particularly passionate about making innovative, evidence-based treatments more accessible and supporting patients through truly personalised medicine.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr. Hariharan Kuhan
Formation et études
-
2010–2016 MD · Medicine and Surgery
-
2016–2020 Residency
-
2020–2021 Fellowship · Subspecialty training
Carrière et postes
-
2020-09–2021-08 Junior consultant
Licences et assurance
Licences médicales
GB — Organización Médica Colegial de España (OMC)
Certifications du conseil
European Board of
Assurance responsabilité professionnelle :
Generali Healthcare · 4,000,000 EUR couverture · No claims on file
Procédures réalisées
| Procédure | Code | Total à vie |
|---|---|---|
| GP consultation | 99213 | 1,527 |
| Annual physical exam | 99395 | 2,361 |
| Vaccination administration | 90471 | 417 |
| Minor procedure (skin) | 17110 | 2,758 |
Services et tarifs
| Service | Durée | Modalité | Prix |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 120 min | in_clinic | 810.00 EUR |
| Minor procedure (skin) | 30 min | in_clinic | 540.00 EUR |
Cabinet, équipe & en pratique
Vidéos
Recherche et publications
indice h : 18 · i10 : 9
-
Outcomes of in adults — a multi-centre cohort
DOI: 10.1289/euroclin.2025.0 · PMID: 33124820 · cité par 39
-
European registry analysis of outcomes
DOI: 10.6802/euroclin.2024.1 · PMID: 30650891 · cité par 157
Conférences invitées
- Practical updates in European Annual Congress () · Vienna · 2024 · invited
- Single-centre experience in National Society Meeting · London · 2023 · oral abstract
Récompenses et adhésions
Récompenses
- 🏆 Top-rated — London · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
Adhésions à des sociétés
- WONCA Europe — Family Doctors — Member · Depuis 2021
- national college of family doctors — Member · Depuis 2021
- European Union of Medical Specialists (UEMS) — Member · Depuis 2021
Articles de ce médecin
- Patient education Patient guide to
- Awareness When should you see a ?
Pour les patients internationaux
- Coordinateur
- Patient liaison · hariharan.kuhan@euroclinics.example
- Assurances internationales acceptées
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
Emplacement
1 baliseAvis des patients
26 avis vérifiés5.00
★★★★★
26 avis
- Bedside Manner
- 5.0
- Knowledge
- 5.0
- Wait Time
- 4.8
- Staff Friendliness
- 5.0
- Ease Of Appointment
- 4.9
- Value For Money
- 4.9
- Would Recommend Pct
- 99.0
Partagez votre expérience — aidez d'autres patients à trouver le bon médecin. Rédiger un avis →
Avis récents
-
★★★★★ ✓ Vérifié Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Vérifié Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Vérifié Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.